Oracle Corporation (ORCL) vs Pfizer Inc. (PFE)
A side-by-side comparison of Oracle Corporation and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ORCL is classified in Technology; PFE is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ORCL
Oracle Corporation
$119.99TechnologyDelayed quote: Jul 28, 2026, 3:59 PM EDT
PFE
Pfizer Inc.
$25.25HealthcareDelayed quote: Jul 28, 2026, 4:02 PM EDT
Total return — ORCL vs PFE
growth of $100 · dividends reinvested · last 30yORCL +3573.7%PFE +543.3%ORCL compounded faster
Log scale — wide-divergence pair
ORCL PFE
ORCL vs PFE: by the numbers
- •ORCL is the larger company ($345.63B vs $143.91B market cap).
- •PFE trades at the lower trailing earnings multiple (18.83 vs 20.57 P/E), one valuation lens rather than an overall verdict.
- •ORCL converts more revenue to profit (25.37% vs 11.83% net margin).
- •ORCL grew revenue faster over the past five years (10.72% vs 8.22% CAGR).
- •PFE pays the higher dividend yield (6.97% vs 1.67%).
Metrics side by side
Valuation
| Metric | ORCL | PFE |
|---|---|---|
| P/E ratio | 20.57 | 18.83 |
| Forward P/E | 16.01 | 8.38 |
| P/S ratio | 5.19 | 2.23 |
| P/B ratio | 8.22 | 1.57 |
| PEG ratio | 1.26 | N/A |
| EV / EBITDA | 16.52 | 9.72 |
| FCF yield | N/A | 6.71% |
Profitability
| Metric | ORCL | PFE |
|---|---|---|
| Gross margin | 65.81% | 69.35% |
| Operating margin | 30.85% | 23.45% |
| Net margin | 25.37% | 11.83% |
| ROE | 40.20% | 8.31% |
| ROIC | 7.99% | 8.84% |
Dividends
| Metric | ORCL | PFE |
|---|---|---|
| Dividend yield | 1.67% | 6.97% |
| Payout ratio | 33.67% | 126.47% |
Growth (annualized)
| Metric | ORCL | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 10.72% | 8.22% |
| EPS CAGR (5Y) | 4.93% | -3.78% |
| FCF CAGR (5Y) | -13.18% | -3.79% |
| Total return CAGR (5Y) | 7.88% | -5.21% |
Frequently asked
- Which has the lower trailing P/E, ORCL or PFE?
- PFE has the lower trailing P/E: ORCL trades at 20.57 and PFE at 18.83. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ORCL or PFE?
- Over the past five years, ORCL grew revenue faster — ORCL at a 10.72% CAGR versus PFE at 8.22%.
- Does ORCL or PFE pay a bigger dividend?
- ORCL yields 1.67% and PFE yields 6.97% based on trailing dividends and the latest price.
- Is ORCL or PFE more profitable?
- ORCL runs the higher net margin — ORCL at 25.37% versus PFE at 11.83%.
- How have ORCL and PFE total returns compared?
- Over the past 10 years, ORCL delivered 13.02% and PFE delivered 1.55% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Oracle P/E ratioPfizer P/E ratioOracle dividend yieldPfizer dividend yieldOracle ROEPfizer ROEOracle operating marginPfizer operating marginOracle revenue growthPfizer revenue growthOracle free cash flowPfizer free cash flow
Oracle & Pfizer appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.